Treat the Leading Cause of Dry Eye with iLux®
Dry eye syndrome is a common condition affecting over 16 million Americans. It occurs when the eye's lacrimal glands fail to produce enough quality tears to nourish and lubricate the eyes. This leads to stinging, burning sensations, light sensitivity, blurred vision, and eye fatigue.
iLux® is an innovative photobiomodulation device designed specifically to treat dry eye. It uses near-infrared light energy to reduce inflammation, stimulate healing, and improve meibomian gland function.
This breakthrough solution directly addresses Meibomian Gland Dysfunction (MGD), the leading cause of dry eyes. This device utilizes near-infrared light to reduce inflammation and stimulate the meibomian glands, enhancing tear production and improving eye comfort.
How Systane iLux® Works
The iLux® device is a sleek, handheld instrument that delivers controlled doses of narrowband near-infrared light at precise wavelengths. When positioned over the affected eye with the integrated safety goggles, this light penetrates tissues and triggers a cascade of beneficial cellular reactions.
Reduced Inflammation
By decreasing pro-inflammatory cytokines, iLux® helps calm inflammation associated with dry eye. This alleviates many symptoms in the short term.
Increased Tear Production
Light stimulation enhances nerve sensitivity and lacrimal gland function, boosting the quality and quantity of natural tear production for long-term improvement.
Promoted Gland Function
Meibomian glands along the eyelid margins can become obstructed in dry eye patients. The photobiomodulation prompts clearing of these obstructions and improves meibum oil release into tears.
Enhanced Tear Film
The ocular surface heals and regenerates with reduced inflammation, healthier meibomian gland secretions, and a more stable tear film. Many signs and symptoms meaningfully improve.
Using iLux® for Dry Eye
Treatment Protocol: iLux® treatment is tailored to each patient's needs, with a typical session lasting just a few minutes.
The recommended frequency can vary based on the severity of symptoms, with some patients experiencing relief after a single session and others requiring multiple treatments for optimal results.
What to Expect: During the treatment, patients may feel a temporary sensation of warmth and notice slight redness in the treated area, both normal and subside quickly.
Over the course of treatments, patients often report a significant improvement in symptoms, including reduced dryness, irritation, and visual disturbances.
Candidates: iLux® is ideally suited for individuals suffering from moderate to severe dry eye, particularly those whose condition stems from Meibomian Gland Dysfunction (MGD).
It offers a non-invasive alternative to traditional treatments, providing relief for those who have not responded to over-the-counter lubricants or prescription therapies.
Symptoms of Dry Eye Disease
Symptoms of dry eye syndrome can vary depending on the severity of the condition but can include:
- Dry, itchy eyes
- Burning or stinging
- Irritation
- Watery eyes
- Blurred vision
- Pain
- Foreign body sensation
Who Can Benefit from iLux® Treatments?
The ideal candidates for iLux® photobiomodulation are those suffering from moderate to severe dry eye symptoms. This includes sensitivity to smoke or wind, unstable or thicker tear film, and substantial impact on daily activities.
Clinical trials display strong results after eight 30-second treatments across four weeks. Patients experience less frequent symptoms, reduced irritation and fatigue, and improved objective signs like meibomian gland capping.
As a painless, convenient treatment with lasting impact, iLux® delivers new hope to the millions tormented by dry eye symptoms. This innovative device offers therapeutic light energy to heal the delicate ocular surface intrinsically.